Ambeed.cn

首页 / / / / S55746

S55746 {[allProObj[0].p_purity_real_show]}

货号:A887253 同义名: BCL201 Ambeed 开学季,买赠积分,赢豪礼

S55746 is a potent and selective inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities.

S55746 化学结构 CAS号:1448584-12-0
S55746 化学结构
CAS号:1448584-12-0
S55746 3D分子结构
CAS号:1448584-12-0
S55746 化学结构 CAS号:1448584-12-0
S55746 3D分子结构 CAS号:1448584-12-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

S55746 纯度/质量文件 产品仅供科研

货号:A887253 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 Bax Bcl-2 Bcl-B Bcl-w Bcl-xL Bfl-1 Mcl-1 其他靶点 纯度
BTSA1 {[allProObj[0].p_purity_real_show]}
HA14-1 +

Bcl-2, IC50: 9 μM

{[allProObj[0].p_purity_real_show]}
Venetoclax ++++

Bcl-2, Ki: <0.01 nM

{[allProObj[0].p_purity_real_show]}
Navitoclax {[allProObj[0].p_purity_real_show]}
Obatoclax Mesylate +++

Bcl-2, Ki: 0.22 μM

{[allProObj[0].p_purity_real_show]}
ABT-737 +++

Bcl-2, EC50: 30.3 nM

+

Bcl-B, EC50: 1.82 μM

+++

Bcl-w, EC50: 197.8 nM

+++

Bcl-xL, EC50: 78.7 nM

{[allProObj[0].p_purity_real_show]}
Gambogic Acid +

Bfl-1, IC50: 1.06 μM

Bcl-2, IC50: 1.21 μM

++

Bcl-B, IC50: 0.66 μM

++++

Bcl-w, IC50: 0.02 μM

+

Bcl-xL, IC50: 1.47 μM

+

Bfl-1, IC50: 1.06 μM

++

Mcl-1, IC50: 0.79 μM

Caspase {[allProObj[0].p_purity_real_show]}
BH3I-1 +

BH3-Bcl-xL interaction, Ki: 2.4 μM

{[allProObj[0].p_purity_real_show]}
A-1331852 ++++

Bcl-xL, Ki: <0.01 nM

{[allProObj[0].p_purity_real_show]}
A-1210477 ++++

MCL-1, IC50: 26.2 nM

{[allProObj[0].p_purity_real_show]}
Maritoclax {[allProObj[0].p_purity_real_show]}
TW-37 +++

Bcl-2, Ki: 0.29 μM

+

Bcl-xL, Ki: 1.11 μM

+++

Mcl-1, Ki: 0.26 μM

{[allProObj[0].p_purity_real_show]}
UMI-77 ++

Mcl-1, Ki: 490 nM

{[allProObj[0].p_purity_real_show]}
(R)-(-)-Gossypol acetic acid ++

Bcl-2, Ki: 0.32 μM

++

Bcl-xL, Ki: 0.48 μM

+++

Mcl-1, Ki: 0.18 μM

{[allProObj[0].p_purity_real_show]}
Sabutoclax ++

Bfl-1, IC50: 0.62 μM

Bcl-2, IC50: 0.32 μM

++

Bcl-xL, IC50: 0.31 μM

++

Bfl-1, IC50: 0.62 μM

+++

Mcl-1, IC50: 0.20 μM

{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

S55746 生物活性

描述 S55746 is a potent, orally active and selective BCL-2 inhibitor with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 is effective in selectively inducing cell death through inhibition of BCL-2 in a BAX/BAK-dependent manner at a concentration of 1 μM[1].

S55746 动物研究

Animal study S55746 is a highly potent and well-tolerated. Administered orally at doses of 20-100 mg/kg, S55746 inhibits xenograft growth in a time- and dose-dependent manner in RS4;11 and Toledo models[1].

S55746 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02603445 Follicular Lymphoma, Mantle Ce... 展开 >>ll Lymphoma 收起 << Phase 1 Completed - United States, New York ... 展开 >> Novartis Investigative Site New York, New York, United States, 10017 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Austria Novartis Investigative Site Salzburg, Austria, 5020 France Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Mainz, Germany, 55131 收起 <<
NCT02920697 Chronic Lymphocytic Leukaemia ... 展开 >>(CLL) B-Cell Non-Hodgkin Lymphoma (NHL) Multiple Myeloma (MM) 收起 << Phase 1 Completed - Australia ... 展开 >> The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia, 3004 France Hopital Claude Huriez Lille, France CHU de Nantes Nantes, France Centre hospitalier Lyon Sud Pierre-Bénite, France Gustave Roussy Villejuif, France Germany Universitätsklinikum Carl Gustav Carus Dresden, Germany Städtisches Klinikum Schwabing Munich, Germany Universitätsklinikum Ulm Ulm, Germany Hungary National Oncology Institute Budapest, Hungary CRU Hungary Kft Miskolc, Hungary Korea, Republic of Severance Hospital Seoul, Korea, Republic of St. Mary's Hospital Seoul, Korea, Republic of Poland Warsaw Institute of Oncology Warsaw, Poland Warsaw Medical University Warsaw, Poland Singapore National Cancer Center (NCC) Singapore, Singapore National University Cancer Institute Singapore Singapore, Singapore United Kingdom University College London Hospitals London, United Kingdom Freeman Hospital Newcastle, United Kingdom 收起 <<

S55746 参考文献

[1]Casara P, et al. S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget. 2018 Apr 13;9(28):20075-20088.

S55746 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.41mL

0.28mL

0.14mL

7.03mL

1.41mL

0.70mL

14.07mL

2.81mL

1.41mL

S55746 技术信息

CAS号1448584-12-0
分子式C43H42N4O6
分子量 710.817
别名 BCL201
运输蓝冰
存储条件

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 50 mg/mL(70.34 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。